
The transition to the “Fourth paradigm” of data-driven science offers a major opportunity for Alzheimer’s disease (AD) and broader neurodegenerative disease (NDD) research. However, this potential is constrained by a “data void” caused by the long preclinical progression of AD pathology. We argue that the large-scale electroencephalography (EEG), when combined with clinical and biological validation, can provide a scalable functional window onto this gap. Yet, the current EEG data landscape emains fragmented, heterogeneous, and difficult to reuse. This perspective review presents a strategic blueprint to address this deadlock. We first examine existing foundational and AD-focused EEG resources. We then distinguish prospective standardization from retrospective harmonization, arguing that both are required to transform isolated recordings into interoperable and clinically validatable evidence. Furthermore, we analyze how advanced artificial intelligence (AI) architectures, including Transformer-based models, depend on robust data governance and explainable AI (XAI) strategies to avoid “Shortcut Learning” and support biological interpretation. Finally, we propose a collaborative ecosystem designed to ensure Robustness, Interpretability, and Scalability (RIS), linking standardized EEG with longitudinal cohorts, human brain banks, and post-mortem neuropathology. Together, this framework aims to transform EEG from a clinical tool into a scalable engine for discovery in AD and related NDDs.
Traumatic brain injury (TBI) is a leading cause of morbidity and mortality worldwide, characterized by complex neurological impairments and systemic consequences. The objective of this systematic review is to assess studies on gut microbiota modulation as a therapy in animal TBI models. The review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. To be eligible for inclusion, publications needed to (1) report original research involving preclinical animal subjects; (2) evaluate the impact of TBI on the microbiome; (3) be written in English; and (4) be published in a peer-reviewed journal. All studies reviewed found changes in the gut microbiome following TBI, with similar alterations in bacterial populations observed across the research. Of 125 records, 9 studies (mice/rats; fluid percussion, Controlled Cortical Impact, and weight-drop models) were included after screening. TBI consistently induces dysbiosis, leaky gut, inflammation, and impaired recovery. Microbiota therapies restore homeostasis, reduce neuroinflammation, and improve outcomes. Microbiota-targeted interventions show significant potential in preclinical models of TBI, effectively mitigating dysbiosis and reducing inflammation. However, translating these findings into clinical settings requires further investigation to establish efficacy and safety in human populations.
Background: China urgently requires a standardized operational protocol for its fetal brain tissue bank. The establishment of such a protocol is essential to address gaps in the current domestic standardized framework, enhance both basic research and clinical studies, and address ethical and sample quality challenges.Materials and methods: By leveraging the practical insights from several domestic brain banks, this protocol defines the goals of fetal brain tissue collection, establishes the legal and ethical foundations for such collection, specifies the range of clinical data to be gathered and the procedures for sampling fetal brain tissue, briefly outlines the standards for pathological diagnosis, details the preservation and management of fetal brain tissue-related information, and explains the principles governing applications for fetal brain tissue use.Results: This protocol provides unified and standardized benchmarks, and strengthens the entire chain of sample collection, processing, and sharing for the establishment of a fetal brain tissue bank.Conclusion: By providing a comprehensive framework, this protocol ensures operational consistency and minimizes experimental bias, thereby facilitating reproducible and comparable research outcomes across institutions. This standardized operational protocol will advance brain science research by ensuring the availability of high-integrity fetal brain tissue samples, ultimately enhancing China’s competitiveness in the international neuroscience community.
Background: The neuropathological diagnosis in post-mortem human brain is the golden standard and crucial for achieving the ultimate goal of serving brain research via human brain banking. With the construction of a China brain bank network, it is urgent to establish a unified protocol, including standardized neuropathological staining protocols, to ensure identical and reliable diagnostic results across different brain banks and to enable future sample sharing for research.Method: This study focused on optimizing immunohistochemical (IHC) staining protocols for four key neuropathological markers of neurodegenerative diseases: hyperphosphorylated Tau protein, β-amyloid, α-synuclein, and phosphorylated transactive response DNA-binding protein 43. The optimization was performed on formalin-fixed, paraffin-embedded human brain tissues by modifying conditions including antigen retrieval. The optimized stainings were compared with those from the highly standardized Netherlands Brain Bank.Results: Through protocol optimization and comparison with the Netherlands Brain Bank standards, we obtained optimal and consistent staining results suitable for reliable neuropathological diagnosis.Discussion: This study provides a solid foundation for quality control of IHC staining and for accurate neuropathological diagnosis within the framework of China brain banking.